Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001221508-12-000015
Filing Date
2012-08-22
Accepted
2012-08-22 17:21:20
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 MLPH FORM 10 K 06-30-2012 form10k_06302012.htm 10-K 579623
2 MLPH FORM EX 32 06-30-2012 ex32a_june302012.htm EX-32 3934
3 MLPH FORM EX 31 06-30-2012 ex312a_june302012.htm EX-31 7733
4 MLPH FORM EX 31 06-30-2012 ex311a_june302012.htm EX-31 7826
  Complete submission text file 0001221508-12-000015.txt   1787028

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE - 2012-06-30 mplh-20120630.xml EX-101.INS 226989
6 XBRLSCHEMA FILE - 2012-06-30 mplh-20120630.xsd EX-101.SCH 10927
7 XBRL IDEFINITION FILE - 2012-06-30 mplh-20120630_def.xml EX-101.DEF 15298
8 XBRL LABLE FILE - 2012-06-30 mplh-20120630_lab.xml EX-101.LAB 88693
9 XBRL PRESENTATION FILE - 2012-06-30 mplh-20120630_pre.xml EX-101.PRE 60572
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50156 | Film No.: 121050373
SIC: 2834 Pharmaceutical Preparations